People

Prof

Ken O’Byrne

MBBS, FRACP, FRCPA, MD

Advanced NSCLC co-chair /

Consultant and Professor in Medical Oncology

Prof Ken O’Byrne is a Consultant and Professor in Medical Oncology recently moved to the Princess Alexandra Hospital (PAH) and the Queensland University of Technology (QUT) section of the Translational Research Institute (TRI) from St James’s Hospital and Trinity College, Dublin.

Prof Ken O’Byrne has conducted translational ‘bench-to-bedside-and back-again’ research over the past 25 years with a focus on solid epithelial tumours, in particular in thoracic malignancies.

Ken was the founder of the British Thoracic Oncology Group (BTOG), and founder member of the European thoracic oncology platform (ETOP), and has held committee positions of the International Association for the Study of Lung Cancer (IASLC).

Ken has been involved in the design of and running phase I, II and III clinical trials encouraging the incorporation of biomarker studies, both prognostic and predictive, where possible. He has published over 250 manuscripts in peer reviewed journals and books and has edited 2 books in thoracic oncology.

TOGA Events:

TOGA Post International Conference Highlights 2024

Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

TOGA

Quicklinks

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.